🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Personalis, Inc.

PSNL Healthcare
$8.34 +$0.39 (4.91%)
Market Cap: $873.37 M
Gurus Holding
6
Popularity Rank
#1292
% of Shares Held
8.19%
Net Activity (Q1 2026)
+$2.29 M

Guru Ownership Trend

Guru Analysis for Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $71.52 M.

Top institutional holders include Catherine Wood and Robert Bruce.

Institutional sentiment is currently Bullish. This is evidenced by a $2.29 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 83.7%.

Key Holders

Top 5 by Value

$50.6 M
$1.48 M
$993,949
$110,978

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$2.79 M
Total Buy Value
New Buys 2
Additions 2
-$495,547.78
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for Personalis, Inc. (PSNL)

Major holders include Catherine Wood ($50.6 M), Robert Bruce ($1.48 M), Paul Tudor Jones ($1.34 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 8.58 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.29 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PSNL. The total reported sell value was $495,547.78.

Yes, 2 managers opened new positions in PSNL, and 2 increased their existing holdings. The total reported buy value was $2.79 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.39% Add 0.8% 7,944,112 $50.6 M Q1 2026
0.42% 233,000 $1.48 M Q1 2026
0.00% New Buy 209,826 $1.34 M Q1 2026
0.01% New Buy 156,036 $993,949 Q1 2026
0.00% Add 70.1% 17,422 $110,978 Q1 2026
0.00% Reduce -83.7% 15,200 $96,824 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form